The goals of this in vitro study were to investigate effects of etomidate on endothelium-dependent relaxation induced by acetylcholine in rat aorta, and to elucidate the associated cellular mechanism. In endothelium-intact rings precontracted with phenylephrine 10 -6 M, dose-response curves for acetylcholine (10 -9 to 10 -5 M) and calcium ionophore (10 -9 to 10 -6 M) were generated in the presence and absence of etomidate (5x10 -6 , 10 -5 M). In endothelium-intact or -denuded rings precontracted with phenylephrine 10 -6 M, sodium nitroprusside (10 -9 to 10 -6 M) dose-response curves were generated in the presence and absence of etomidate (10 -5 M). Etomidate (5x10 -6 , 10 -5 M) produced a significant rightward shift in the dose-response curves induced by acetylcholine (receptor-mediated endothelium-dependent agonist) and calcium ionophore A23187 (non receptor-mediated endothelium-dependent agonist). Etomidate (10 -5 M) had no effect on sodium nitroprusside (endothelium-independent nitric oxide donor)induced vasorelaxant response in both endothelium-intact and -denuded rings. These results indicate that etomidate at clinically relevant concentrations attenuates endothelium-dependent relaxation induced by acetylcholine by an acting at a site distal to the endothelial muscarinic receptor, but proximal to guanylate cyclase activation of vascular smooth muscle in rat aorta.
Endothelial cells contribute to the local regulation of vasomotor tone by releasing dilator and constrictor substances. The vascular endothelium releases endothelium-derived relaxing factor (EDRF) 1 which relaxes vascular smooth muscle by the formation of 3', 5'-cyclic guanosine monophosphate (cyclic GMP) 2 through activation of guanylate cyclase (GC). In rat aorta, release of EDRF evoked by acetylcholine is mediated by the activation of endothelial M 3 muscarinic receptor subtype 3 . Anaesthetics including inhalation anaesthetics 4, 5 (halothane, enflurane, iso-flurane), local anaesthetics 6 (bupivacaine, lidocaine, etidocaine, 2-chloroprocaine) and intravenous anaesthetics 7, 8, 9 (thiopentone, ketamine, propofol) attenuate endothelium-dependent vasorelaxation induced by acetylcholine or methacholine.
Etomidate 10 , which has minimal effect on cardiovascular function, has been used for anaesthetizing patients whose haemodynamic stability must be maintained. Etomidate attenuates acetylcholine-induced relaxation in canine pulmonary artery 11 , and inhibits the endothelium-derived hyperpolarizing factor (EDHF)-mediated relaxant response to acetylcholine in the human renal artery 12 . However, to our knowledge, the effects of etomidate on acetylcholineinduced relaxation in systemic circulation such as rat aorta have not been investigated previously. The goals of this in vitro study were to investigate the effects of etomidate on endothelium-dependent relaxation induced by acetylcholine in rat aorta, and to elucidate the associated cellular mechanism.
MATERIALS AND METHODS
All the experimental procedures and protocols were approved by the Institutional "Animal Care and Use" Committee of Gyeongsang National University Hospital.
Preparation of aortic rings for tension measurement:
Male Sprague Dawley rats weighing 250-350 g were anaesthetized with intraperitoneal administration of sodium pentobarbital (50 mg/kg). The descending thoracic aorta was dissected free, and surrounding connective tissue and fat were removed under microscope while the vessel was bathed in Krebs solution of the following composition (mM): NaCl 118, KCl 4.7, MgSO 4 1.2, KH 2 PO 4 1.2, CaCl 2 2.4, NaHCO 3 25, glucose 11, EDTA 0.03. The aorta was then cut into 2.5-3 mm rings, which were suspended on Grass isometric transducers (FT-03, Grass Instrument, Quincy, MA, U.S.A.) at 2.0 g resting tension in 10 ml temperature-controlled baths (37°C) containing Krebs solution continuously gassed with 95% O 2 and 5% CO 2 . The rings were equilibrated at 2.0 g resting tension for 120 minutes during which the bathing solution was changed every 15 minutes. Care was taken not to damage the endothelium. In some aortic rings, the endothelium was intentionally removed by inserting a 25-gauge needle tip into the lumen of the ring and gently rolling the ring for a few seconds. Only one concentration-response curve elicited by endothelium-dependent relaxing agents (acetylcholine or calcium ionophore A23187) or endothelium-independent relaxing agent (sodium nitroprusside) was made from each ring in all the experiments.
Experiment Protocols: Etomidate was directly added to the organ bath 15 minutes before phenylephrineinduced contraction in all the experimental protocols. Subsequently, contraction was induced with phenylephrine 10 -6 M. When the contractile response to phenylephrine 10 -6 M was stabilized, incremental concentrations of acetylcholine (10 -9 to 10 -5 M) and calcium ionophore A23187 (10 -9 to 10 -6 M) were added to the organ bath to generate the concentrationresponse curves in the endothelium-intact rings. Each ring was exposed to only one endothelial activator. When the contractile response to phenylephrine 10 -6 M was stabilized, incremental concentrations of the endothelium-independent nitric oxide donor, sodium nitroprusside (10 -9 to 10 -6 M) were added to the organ bath to generate the concentrationresponse curves in both endothelium-intact and -denuded rings. The effects of etomidate (5x10 -6 and 10 -5 M) on the concentration-response curves for these vasodilators (acetylcholine, calcium ionophore A23187 and sodium nitroprusside) were assessed by comparing vasorelaxant responses in the presence and absence of etomidate.
Drugs and Solutions: All drugs were of the highest purity commercially available: phenylephrine HCl, acetylcholine, calcium ionophore A23187, sodium nitroprusside (Sigma chemical, St. Louis, MO, U.S.A.), etomidate (Etomidate Lipuro, B. Braun, Melsungen, German), Lipofundin MCT/LCT 20% (B.Braun, Melsungen, German). All concentrations are expressed as the final molar concentration in the organ bath. Calcium ionophore A23187 was initially dissolved in dimethyl sulphoxide (DMSO 0.05% v/v) 7 and subsequently diluted in distilled water. Unless stated otherwise, drugs were dissolved in distilled water.
Data Analysis: Vasorelaxant responses to acetylcholine, calcium ionophore A23187 and sodium nitroprusside (SNP) were expressed as the percentage relaxation of the precontraction induced by phenylephrine 10 -6 M. The logarithm of drug concentration eliciting 50% of the maximal relaxation response (ED 50 ) was calculated by non-linear regression analysis by fitting concentration-response relationship for each vasorelaxant to a sigmoidal curve using commercially available software (Prism version 2.0; Graph Pad Software, San Diego, CA, U.S.A.). The maximal response (R max ) to each vasorelaxant was measured with R max =100% indicating complete reversal of phenylephrine-induced contraction. Statistical analysis was performed using one-way analysis of variance followed by Scheffé F-test or Student's t test for paired samples. Differences were considered statistically significant at P<0.05. Sample size (N value) refers to the number of rats whose descending thoracic aortic rings were used in each protocol.
RESULTS
Etomidate 5x10 -6 , 10 -5 M (mean, SD) significantly attenuated (P<0.05) the vasorelaxation induced by the receptor-mediated endothelium-dependent agonist, acetylcholine, in endothelium-intact rings (Table 1, Figure 1 ). The vehicle (Lipofundin MCT/LCT 20%) for etomidate had no effect on the vasorelaxant response to acetylcholine in endotheliumintact rings ( Table 1) . Etomidate 5x10 -6 , 10 -5 M significantly attenuated (P<0.05) the vasorelaxation induced by the non receptor-mediated endotheliumdependent agonist, calcium ionophore A23187, in endothelium-intact rings (Table 2, Figure 2 ). Etomidate 10 -5 M had no effect on the vasorelaxation induced by the endothelium-independent nitric oxide (NO) donor, sodium nitroprusside, in both endothelium-denuded (Table 3, Figure 3 ) and -intact (Table 3, Figure 4 ) rings.
DISCUSSION
This is the first study to demonstrate that etomidate (5x10 -6 M and 10 -5 M) attenuates endothelium-dependent relaxation induced by the muscarinic receptor-mediated agent, acetylcholine, and the nonreceptor-mediated agonist, calcium ionophore A23187, in rat aorta. In contrast, etomidate 10 -5 M has no effect on the endothelium-independent vasorelaxation induced by sodium nitroprusside in both endothelium-intact and -denuded rings. Taken together, these results indicate that etomidate appears to inhibit endothelium-dependent relaxation induced by acetylcholine at a site distal to the endothelial muscarinic receptor, but proximal to guanylate cyclase (GC) activation in vascular smooth muscle of rat aorta. (NOS) from L-arginine in mammalian cells activates GC, resulting in an increase in smooth muscle cGMP production, which correlates with its relaxing effect 13 ( Figure 5 ). The NOSs for release of NO in endothelial cells bind calmodulin in a calcium (Ca 2+ )dependent manner 13 (Figure 5 ). Calcium ionophore A23187 increases free intracellular Ca 2+ ([Ca 2+ ] i ) in endothelium by increasing the Ca 2+ permeability of the cell membrane, as well as intracellular organelles containing Ca 2+ . An increased endothelial cytoplasmic free Ca 2+ induced by calcium ionophore A23187 at low concentration, in conjunction with calmodulin and NADPH (nicotinamide adenine dinucleotide phosphate), activates NOS 14, 15 (Figure 5 ). Although unstimulated endothelial cells continuously produce NO, NOS activity can be enhanced by both receptor-dependent agonists (acetylcholine, adenosine triphosphate, bradykinin) and a receptor-independent agonist (calcium ionophore A23187) 13 (Figure 5 ). Etomidate attenuated the vasorelaxant response to acetylcholine and calcium ionophore A23187 in endothelium-intact rings. These results imply that etomidate is not causing attenuation solely by an action at the endothelial muscarinic receptor, but must be acting at a site distal to endothelial muscarinic receptor activation. To investigate the effects of etomidate on NO transfer from endothelium to vascular smooth muscle, the effects of etomidate 10 -5 M on sodium nitroprusside-induced vasorelaxation were assessed in endothelium-intact rings. Etomidate 10 -5 M had no effect on the vasorelaxant response to the endothelium-independent nitric oxide donor, sodium nitroprusside, in both endothelium-denuded and -intact rings. Because vasorelaxation in response to the endotheliumindependent NO donor, sodium nitroprusside (which activates vascular smooth muscle GC), was not inhibited by etomidate 10 -5 M in endothelium-denuded and endothelium-intact rings, it is unlikely that etomidate causes attenuation by inhibiting NO transfer from endothelium to smooth muscle. Previous studies have shown that etomidate attenuates the vasorelaxant response to acetylcholine and bradykinin by inhibiting both NO and EDHF mediated components in canine pulmonary artery 11 . Etomidate also inhibits the EDHF-mediated component of acetycholine-induced relaxation in isolated human renal artery 12 . Etomidate attenuates EDHFmediated component of vasorelaxant response to bradykinin in the rat coronary microcirculation 16 . In contrast to the pulmonary circulation and coronary circulation, very little is known about the effects of etomidate on the NO-mediated component of acetylcholine-induced vasorelaxation in the systemic circulation. Propofol and ketamine inhibit the NOmediated component of acetylcholine-induced relaxation in rat aorta 9 . Like other intravenous anaesthetics 9 such as ketamine and propofol, etomidate also attenuated endothelium-dependent relaxation induced by acetylcholine in rat aorta.
The three primary endothelial vasodilators are NO, EDHF and prostacyclin. Although etomidate has no effect on calcium ionophore A23187-induced relaxation in canine pulmonary artery 11 , it appears that etomidate attenuates calcium ionophore A23187induced relaxation in rat aorta. Nitric oxide and EDHF are the primary mediators of endotheliumdependent relaxation induced by acetylcholine and calcium ionophore A23187 in canine pulmonary artery 17 . However, NO is the main mediator of 479 
ETOMIDATE AND ACETYLCHOLINE-INDUCED VASORELAXATION
Anaesthesia and Intensive Care, Vol. 32, No. 4, August 2004 FIGURE 3: Effect of etomidate on the sodium nitroprusside doseresponse curve in endothelium-denuded rings. Etomidate 10 -5 M had no effect on the sodium nitroprusside dose-response curve. FIGURE 4: Effect of etomidate on the sodium nitroprusside (SNP) dose-response curve in endothelium-intact rings. Etomidate 10 -5 M had no effect on the sodium nitroprusside dose-response curve. endothelium-dependent relaxation induced by acetylcholine and calcium ionophore A23187 in rat aorta because the NOS inhibitor, L -NAME (L -nitroarginine methyl ester) nearly abolishes the vasorelaxant response induced by acetylcholine and calcium ionophore A23187 7, 18 . This different effect of etomidate on calcium ionophore A23187-induced relaxation may be ascribed to the difference of the main endothelium-derived vasodilators responsible for calcium ionophore A23187-induced relaxation in canine pulmonary artery and rat aorta. Etomidate 10 -3 M has been reported to inhibit NOS activity from isolated human polymorphonuclear leucocytes 19 . Taking into account the findings previously mentioned 19 , we can suppose that a possible mechanism of etomidate-induced inhibition of the endotheliumdependent vasorelaxation induced by acetylcholine and calcium ionophore A23187 may be the consequence essentially of an interference with the activity of NOS. The specific sites and mechanisms of this inhibition in the rat aortic endothelial cells remain to be determined.
The peak plasma concentration of etomidate during induction of general anaesthesia is approximately 10 -5 M 20,21 , whereas the free plasma concentration is likely to be less than 10 -5 M because about 76.5% of etomidate 22 is bound to plasma protein. Thus, the inhibitory effects of etomidate of endotheliumdependent vasorelaxation induced by acetylcholine in this study appear to be significant at clinically relevant concentrations.
Etomidate-induced inhibition of NO-mediated relaxation induced by acetylcholine in rat aorta does not imply that etomidate constricts rat aorta. Etomidate (5x10 -5 and 10 -4 M) attenuates phenylephrineinduced contraction in rat aorta via an inhibitory effect on L-type calcium channels in the vascular smooth muscle of rat aorta 23 FIGURE 5: Scheme of the major signal transduction pathways of production and release of nitric oxide (NO) from endothelial cells and its action in vascular smooth muscle. The formation of NO from L-arginine is catalysed by nitric oxide synthase (NOS). A NOS is NADPH (nicotinamide adenine dinuclotide phosphate)-dependent oxygenase which binds calmodulin in a calcium dependent (Ca ++ )manner; therefore NOS activity can be enhanced by the receptor-dependent agonists (acetylcholine, adenosine triphophate, bradykinin) or the receptorindependent agonist (calcium ionophore A23187), which increase the concentration of free intracellular Ca ++ . NO relaxes vascular smooth muscle by the formation of 3', 5'-cyclic guanosine monophosphate (cyclic GMP) through activation of guanylate cyclase (GC). Endothelium-independent NO donors, sodium nitroprusside (SNP) and nitroglycerin (NTG) activate GC, and they act directly on the vascular smooth muscle. patients undergoing cerebral aneurysm surgery 24 . No inhibition on contractility of isolated human atrial tissue was found in the clinical concentration ranges of etomidate 25 , and etomidate 26 2 mg/kg increases blood pressure in wild-type mice via an alpha 2βadrenoceptor-mediated vasocontriction. Taking into consideration the above studies [23] [24] [25] [26] , the net haemodynamic effects of etomidate in vivo are a composite of vascular, myocardial and neural effects. In vivo, a basal release of EDRF can be stimulated by shear stress imposed by blood flow on the luminal surfaces of endothelial cells, and the flow-induced endothelium-dependent regulation of the tone of large arteries may be of physiological importance on regional haemodynamics 27 . As basal release of EDRF is important in the control of blood pressure, etomidate-induced inhibition of EDRF production stimulated by acetylcholine may be an important component of net haemodynamic effects of etomidate on the cardiovascular system. These findings may contribute to an understanding of the combined effects of etomidate on the endothelium.
In conclusion, this study has shown that etomidate at clinically relevant concentrations attenuates endothelium-dependent relaxation induced by acetylcholine by an acting at a site distal to endothelial muscarinic receptor but proximal to GC activation in the vascular smooth muscle of rat aorta.
